PUBLISHER: TechSci Research | PRODUCT CODE: 1743715
PUBLISHER: TechSci Research | PRODUCT CODE: 1743715
We offer 8 hour analyst time for an additional research. Please contact us for the details.
The Global Compression Therapy Market was valued at USD 4.28 billion in 2024 and is projected to reach USD 5.34 billion by 2030, growing at a CAGR of 3.76% over the forecast period. This market is experiencing significant growth, primarily due to the increasing prevalence of venous disorders such as leg ulcers, deep vein thrombosis, varicose veins, lymphedema, and blood clots. The rising incidence of chronic conditions like diabetes, cardiovascular diseases, and obesity-often associated with venous complications-is further fueling demand for compression therapy solutions. Compression therapy, delivered through products such as stockings, bandages, sleeves, pumps, and garments, has emerged as an effective non-invasive treatment for improving blood circulation, reducing swelling, and managing chronic wounds. Technological advancements, expanding product variety, and increased awareness of the benefits of compression therapy are also boosting market adoption. Additionally, the growing aging population and supportive healthcare reimbursement frameworks across developed markets are supporting further expansion. The market is seeing increased product innovation and digital integration, which are improving patient outcomes and treatment compliance across various applications in both clinical and home care settings.
Market Overview | |
---|---|
Forecast Period | 2026-2030 |
Market Size 2024 | USD 4.28 Billion |
Market Size 2030 | USD 5.34 Billion |
CAGR 2025-2030 | 3.76% |
Fastest Growing Segment | Compression Pumps |
Largest Market | North America |
Key Market Drivers
Rising Prevalence of Venous Disorders and Chronic Wounds
The global surge in venous and lymphatic disorders-such as chronic venous insufficiency, deep vein thrombosis, and lymphedema-is a major driver of the compression therapy market. These conditions are increasingly linked to aging populations, sedentary behavior, and rising obesity rates. Compression therapy is widely endorsed for its role in improving venous return and promoting healing of chronic wounds like venous leg ulcers. According to the CDC, around 900,000 people in the U.S. are affected annually by DVT or pulmonary embolism, with tens of thousands of resulting deaths. Similarly, the WHO highlights the increasing prevalence of chronic wounds in elderly and diabetic populations. Clinical guidelines across healthcare systems, including the UK's NHS, routinely recommend compression garments and bandages for managing venous ulcers and post-thrombotic syndrome. Reimbursement coverage by insurers further supports market growth, while public health initiatives continue to emphasize early intervention through compression therapy for effective long-term disease management.
Key Market Challenges
Lack of Awareness and Underutilization in Low- and Middle-Income Countries
Despite its proven effectiveness, compression therapy remains underused in many low- and middle-income countries (LMICs) due to limited awareness and accessibility. In these regions, venous and lymphatic disorders often go undiagnosed or are treated inadequately, largely due to the lack of healthcare provider training and infrastructure. WHO and World Bank data show that over half of the global population lacks access to essential healthcare services, with chronic wound care and vascular treatment receiving minimal attention in resource-constrained settings. Socioeconomic challenges also hinder adoption; many patients cannot afford compression products or are unfamiliar with their use. In regions like India and Sub-Saharan Africa, less than a third of patients with venous ulcers receive appropriate compression therapy. While governments are beginning to recognize the long-term economic burden of untreated chronic wounds, comprehensive investments in healthcare training, public awareness, and subsidized access are still necessary to improve adoption in these underserved areas.
Key Market Trends
Integration of Smart Textiles and Wearable Technology
The convergence of compression therapy with smart textile and wearable technology is emerging as a key market trend. These next-generation compression garments incorporate sensors, wireless connectivity, and real-time monitoring capabilities to optimize therapy. Features such as pressure adjustment, limb circumference tracking, and patient activity feedback help personalize treatment and boost adherence. For instance, e-textiles funded by Horizon 2020 in Europe are being developed to offer adaptive compression based on physiological changes, which is especially beneficial for conditions like lymphedema. Clinical trials in the U.S. and Europe are also exploring connected compression systems that relay treatment data to healthcare providers for better outcome tracking. Government initiatives such as NSF's wearable health technology grants in the U.S. and Japan's IoT-driven healthcare strategies are supporting these innovations. The integration of digital health tools is reshaping compression therapy, shifting care from reactive to proactive and elevating patient-centered treatment models in both hospital and home settings.
In this report, the Global Compression Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Compression Therapy Market.
Global Compression Therapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: